{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-144194","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.229479+00:00","generated_at":"2026-06-15T01:19:16.971666+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Avantor CFO Thomas Szlosek to depart Aug 2, 2023; FY2023 guidance reaffirmed","bullets":["CFO Thomas Szlosek resigns effective August 2, 2023 to join a company outside life sciences.","Szlosek's departure is not due to any disagreement with Avantor's operations, policies, or practices.","Avantor has initiated a search for a new CFO; Szlosek will remain through Q2 earnings announcement.","Company reaffirms fiscal 2023 financial guidance provided on April 28, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-144194","json":"https://secwatch.observer/filing/0001193125-23-144194.json","markdown":"https://secwatch.observer/filing/0001193125-23-144194.md","text":"https://secwatch.observer/filing/0001193125-23-144194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000119312523144194/0001193125-23-144194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000119312523144194/d478163d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T01:19:16.971666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad13ba70f9","claim":"Thomas A. Szlosek resigned as Executive Vice President and Chief Financial Officer at Avantor, Inc..","evidence_excerpt":"On May 9, 2023, Mr. Thomas A. Szlosek notified the Company of his decision to resign as the Company’s Executive Vice President and Chief Financial Officer (“CFO”), effective as of August 2, 2023, to join a company outside the life sciences industry.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1722482/000119312523144194/0001193125-23-144194-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}